Eagleye you are right Ujjavn FY 17 book value 143 & I expect Ujjavan trade mim. 2.7-3.5 Fy 17 book value because equitas se Ujjavan bahut acchi company hai itana pe to Banta hai I expect listing minimum 300+ price & I hold Ujjavan for long term for price 450+
I ve navkar corp ,s h kelkar , quick heal ,Equitas & alkem lab in my portfolio .....wht should I do in above mentioned script s which R holding or sale ....plz guide me thanks
Navkar is a stock which I am myself looking to buy but it''s pricey at present(186/-). I see good future for it. So, don''t sell if ur holding it since IPO days i.e.at 155/-. At least wait until GST.
Hi experts.. Pls advise me here as m new to market. I have got allotment of 1215 shares of equitas which I haven''t sold yet. I will be applying TTL. Now to apply for Ujivan I need to sale equitas due to fund problem. My query is what is advisable 1) Hold equitas and ignore Ujivan 2) apply ujivan and ignore TTL 3) sale equitas on Monday and appliy for TTL and ujivan. Answer expected from septa and eagleeye.
130.1. Eagleye| Link| Bookmark|
April 24, 2016 12:20:19 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Manojbhai,
Thyrocare is a good punt to buy in IPO but then sell soon after listing.
Whereas, Equitas & Ujjivan are both super good quality stocks to keep in long term portfolio
That''s the advise I have been given by market experts ...
Yes Demat account can be open in the name of a minor. The account will be operated by a guardian till the minor becomes major, Guardian has to be the father or in his absence mother. In absence of both, father or mother, the guardian can be appointed by court.
Thirocare IPO has 200 GMP and UFL IPO has 40 GMP from this it appears that TTL has more potential than UFL. But technically and Fundamentally UFL strong.